Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets

被引:0
作者
Saki Nakagawa
Yasuhiro Miki
Minoru Miyashita
Shuko Hata
Yayoi Takahashi
Yoshiaki Rai
Yasuaki Sagara
Yasuyo Ohi
Hisashi Hirakawa
Kentaro Tamaki
Takanori Ishida
Mika Watanabe
Takashi Suzuki
Noriaki Ohuchi
Hironobu Sasano
机构
[1] Tohoku University Graduate School of Medicine,Department of Surgical Oncology
[2] Tohoku University Hospital,Department of Pathology
[3] Tohoku University Graduate School of Medicine,Department of Pathology
[4] Social Medical Corporation Hakuaikai,Department of Breast Surgery, Sagara Hospital
[5] Social Medical Corporation Hakuaikai,Department of Pathology, Sagara Hospital
[6] Tohoku Kosai Hospital,Department of Breast Surgery
来源
Breast Cancer Research and Treatment | 2016年 / 155卷
关键词
Invasive lobular carcinoma; Cancer-associated fibroblasts; Microvessel density; Vasohibin-1 positive ratio; Nestin; Insulin-like growth factor-1;
D O I
暂无
中图分类号
学科分类号
摘要
Invasive ductal and lobular carcinomas (IDC and ILC) are the two most common histological types of breast cancer, and have been considered to develop from terminal duct lobular unit but their molecular, pathological, and clinical features are markedly different between them. These differences could be due to different mechanisms of carcinogenesis and tumor microenvironment, especially cancer-associated fibroblasts (CAFs) but little has been explored in this aspect. Therefore, in this study, we evaluated the status of angiogenesis, maturation of intratumoral microvessels, and proliferation of CAFs using immunohistochemistry and PCR array analysis to explore the differences of tumor microenvironment between ILC and IDC. We studied grade- and age-matched, luminal-like ILC and IDC. We immunolocalized CD34 and αSMA for an evaluation of CAFs and CD31, Vasohibin-1, a specific marker of proliferative endothelial cells and nestin, a marker of pericytes for studying the status of proliferation and maturation of intratumoral microvessel. We also performed PCR array analysis to evaluate angiogenic factors in tumor stromal components. The number of CAFs, microvessel density, and vasohibin-1/CD31 positive ratio were all significantly higher in ILC than IDC but nestin immunoreactivity in intratumoral microvessel was significantly lower in ILC. These results did indicate that proliferation of CAFs and endothelial cells was more pronounced in ILC than IDC but newly formed microvessels were less mature than those in IDC. PCR array analysis also revealed that IGF-1 expression was higher in ILC than IDC. This is the first study to demonstrate the differences of tumor microenvironment including CAFs and proliferation and maturation of intratumoral vessels between ILC and IDC.
引用
收藏
页码:65 / 75
页数:10
相关论文
共 188 条
[1]  
Fisher ER(1975)The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4) Cancer 36 1-85
[2]  
Gregorio RM(2004)Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome Breast Cancer Res 6 R149-R156
[3]  
Arpino G(1996)Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns Cancer 77 113-120
[4]  
Bardou VJ(2007)Primary systemic chemotherapy of invasive lobular carcinoma of the breast Lancet Oncol 8 55-62
[5]  
Sastre-Garau X(2001)Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 10869-10874
[6]  
Jouve M(2013)The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients Breast 22 1119-1124
[7]  
Katz A(2010)Invasive lobular versus ductal breast cancer: a stage-matched comparison of outcomes Ann Surg Oncol 17 1862-1869
[8]  
Saad ED(2001)E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? Breast Cancer Res 4 5-8
[9]  
Sorlie T(2003)Is invasive lobular carcinoma different from invasive ductal carcinoma? Eur J Surg Oncol 29 390-395
[10]  
Perou CM(2015)Differences in response and surgical management with neoadjuvant chemotherapy in invasive lobular versus ductal breast cancer Ann Surg Oncol 87 1105-1111